• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
75,946.34 -63.36
( -0.08%)
Global Indices
Nasdaq
50,493.86 -106.84
(-0.21%)
Dow Jones
7,540.47 46.00
(0.61%)
Hang Seng
65,194.32 198.23
(0.30%)
Nikkei 225
10,499.42 33.16
(0.32%)
Forex
USD-INR
95.26 -0.35
(-0.37%)
EUR-INR
110.89 -0.08
(-0.07%)
GBP-INR
128.53 0.11
(0.08%)
JPY-INR
0.60 0.00
(-0.21%)

EQUITY - MARKET SCREENER

Medico Remedies Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
540937
INE630Y01024
9.0953437
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
MEDICO
30.4
398.57
EPS(TTM)
Face Value()
Div & Yield %
1.58
2
0
 

Sanofi India standalone net profit declines 14.14% in the March 2026 quarter
Apr 29,2026
Net profit of Sanofi India declined 14.14% to Rs 102.60 crore in the quarter ended March 2026 as against Rs 119.50 crore during the previous quarter ended March 2025. Sales declined 11.87% to Rs 472.30 crore in the quarter ended March 2026 as against Rs 535.90 crore during the previous quarter ended March 2025.

ParticularsQuarter Ended
Mar. 2026Mar. 2025% Var.
Sales472.30535.90 -12
OPM %30.2432.08 -
PBDT146.90174.90 -16
PBT137.90165.30 -17
NP102.60119.50 -14